Norges Bank’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-178,000
| Closed | -$1.55M | – | 1395 |
|
|
2025
Q2 | $1.55M | Hold |
178,000
| – | – | ﹤0.01% | 1472 |
|
|
2025
Q1 | $1.42M | Hold |
178,000
| – | – | ﹤0.01% | 1577 |
|
|
2024
Q4 | $1.62M | Buy |
+178,000
| New | +$1.72M | ﹤0.01% | 1711 |
|
|
2024
Q3 | – | Sell |
-1,527,077
| Closed | -$14.9M | – | 1954 |
|
|
2024
Q2 | $14.9M | Buy |
1,527,077
+771,876
| +102% | +$9.41M | ﹤0.01% | 1288 |
|
|
2024
Q1 | $11.4M | Buy |
755,201
+304,436
| +68% | +$5.52M | ﹤0.01% | 1414 |
|
|
2023
Q4 | $9.71M | Sell |
450,765
-994,875
| -69% | -$18.4M | ﹤0.01% | 1493 |
|
|
2023
Q3 | $26.9M | Sell |
1,445,640
-119,241
| -8% | -$2.78M | 0.01% | 1110 |
|
|
2023
Q2 | $39.6M | Buy |
1,564,881
+400,077
| +34% | +$10.1M | 0.01% | 967 |
|
|
2023
Q1 | $30.2M | Sell |
1,164,804
-299,543
| -20% | -$8.02M | 0.01% | 1074 |
|
|
2022
Q4 | $34.6M | Sell |
1,464,347
-61,615
| -4% | -$1.66M | 0.01% | 976 |
|
|
2022
Q3 | $38.7M | Buy |
1,525,962
+150,838
| +11% | +$5.29M | 0.01% | 881 |
|
|
2022
Q2 | $45.7M | Sell |
1,375,124
-106,241
| -7% | -$4.51M | 0.01% | 812 |
|
|
2022
Q1 | $107M | Buy |
1,481,365
+197,738
| +15% | +$14.2M | 0.02% | 563 |
|
|
2021
Q4 | $118M | Buy |
1,283,627
+81,745
| +7% | +$9.77M | 0.02% | 550 |
|
|
2021
Q3 | $152M | Buy |
1,201,882
+66,510
| +6% | +$9.68M | 0.03% | 488 |
|
|
2021
Q2 | $189M | Buy |
1,135,372
+323,017
| +40% | +$52.3M | 0.04% | 429 |
|
|
2021
Q1 | $148M | Sell |
812,355
-31,731
| -4% | -$7.36M | 0.03% | 488 |
|
|
2020
Q4 | $169M | Buy |
844,086
+297,669
| +54% | +$60.5M | 0.04% | 418 |
|
|
2020
Q3 | $120M | Buy |
546,417
+27,463
| +5% | +$5.82M | 0.03% | 479 |
|
|
2020
Q2 | $99M | Sell |
518,954
-140,349
| -21% | -$24.6M | 0.03% | 500 |
|
|
2020
Q1 | $102M | Buy |
659,303
+50,087
| +8% | +$5.83M | 0.04% | 425 |
|
|
2019
Q4 | $51M | Sell |
609,216
-26,478
| -4% | -$2.01M | 0.01% | 905 |
|
|
2019
Q3 | $43M | Sell |
635,694
-62,740
| -9% | -$4.13M | 0.01% | 958 |
|
|
2019
Q2 | $46.4M | Hold |
698,434
| – | – | 0.01% | 918 |
|
|
2019
Q1 | $38.8M | Buy |
698,434
+50,620
| +8% | +$3.09M | 0.01% | 1031 |
|
|
2018
Q4 | $32.1M | Buy |
647,814
+62,659
| +11% | +$3.83M | 0.01% | 1075 |
|
|
2018
Q3 | $50.5M | Buy |
585,155
+384,830
| +192% | +$27.4M | 0.02% | 862 |
|
|
2018
Q2 | $11.6M | Buy |
200,325
+154,196
| +334% | +$7.53M | ﹤0.01% | 1764 |
|
|
2018
Q1 | $1.86M | Hold |
46,129
| – | – | ﹤0.01% | 2006 |
|
|
2017
Q4 | $1.61M | Buy |
46,129
+18,313
| +66% | +$608K | ﹤0.01% | 2004 |
|
|
2017
Q3 | $922K | Buy |
+27,816
| New | +$912K | ﹤0.01% | 2072 |
|
Other funds holding TDOC
Norges Bank's TDOC Position: Q3 2025 in Review
Norges Bank sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 178,000 shares — an estimated $1.55M sold.
Norges Bank first reported a position in TDOC in Q3 2017 and held it in 31 quarters. The position peaked at $189M in Q2 2021. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.
- Norges Bank reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
- Norges Bank sold 178,000 Teladoc Health shares in Q3 2025, an estimated $1.55M.
- Norges Bank first reported a position in Teladoc Health in Q3 2017 and held it in 31 quarters.
- Norges Bank's Teladoc Health position peaked at $189M in Q2 2021.
- 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.
Based on Norges Bank's 13F filing for Q3 2025.